|
Q1 FY2021
As of Jul 31, 2020
|
Q4 FY2020
As of Apr 30, 2020
|
Q3 FY2020
As of Jan 31, 2020
|
Q2 FY2020
As of Oct 31, 2019
|
Q1 FY2020
As of Jul 31, 2019
|
Q4 FY2019
As of Apr 30, 2019
|
Q3 FY2019
As of Jan 31, 2019
|
Q2 FY2019
As of Oct 31, 2018
|
Q3 FY2013
As of Jan 31, 2013
|
Q2 FY2013
As of Oct 31, 2012
|
Q4 FY2012
As of Apr 30, 2012
|
Q3 FY2012
As of Jan 31, 2012
|
Q2 FY2012
As of Oct 31, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| Current Assets | |||||||||||||
| Cash and Cash Equivalents | |||||||||||||
| Prepaid Expenses | |||||||||||||
| Total Current Assets | |||||||||||||
| Total Assets | |||||||||||||
| LIABILITIES AND SHAREHOLDERS' DEFICIT | |||||||||||||
| Current Liabilities | |||||||||||||
| Fees Drawn in Excess of Bank Balance | |||||||||||||
| Accounts Payable and Accruals | |||||||||||||
| Accruals - Related Parties | |||||||||||||
| Note Payable | |||||||||||||
| Loans - Related Parties | |||||||||||||
| Total Current Liabilities | |||||||||||||
| Total Liabilities | |||||||||||||
| Shareholders' Deficit | |||||||||||||
| Preferred Stock, $0.001 par value, 10,000,000 authorized none issued and outstanding | |||||||||||||
| Common Stock, $0.001 par value, 250,000,000 authorized, 249,843,977 issued and outstanding | |||||||||||||
| Additional Paid in Capital | |||||||||||||
| Accumulated Deficit | |||||||||||||
| Total Shareholders' Deficit | |||||||||||||
| Total Liabilities and Shareholders' Deficit | |||||||||||||
Loading...